SG11201601939VA - Method - Google Patents

Method

Info

Publication number
SG11201601939VA
SG11201601939VA SG11201601939VA SG11201601939VA SG11201601939VA SG 11201601939V A SG11201601939V A SG 11201601939VA SG 11201601939V A SG11201601939V A SG 11201601939VA SG 11201601939V A SG11201601939V A SG 11201601939VA SG 11201601939V A SG11201601939V A SG 11201601939VA
Authority
SG
Singapore
Prior art keywords
method
Prior art date
Application number
SG11201601939VA
Inventor
Sai Kiang Lim
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SG2013069661 priority Critical
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to PCT/SG2014/000434 priority patent/WO2015038075A1/en
Priority to SG11201601939VA priority patent/SG11201601939VA/en
Publication of SG11201601939VA publication Critical patent/SG11201601939VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0008Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/001Preparations to induce tolerance to non-self, e.g. prior to transplantation
SG11201601939VA 2013-09-16 2014-09-15 Method SG11201601939VA (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SG2013069661 2013-09-16
PCT/SG2014/000434 WO2015038075A1 (en) 2013-09-16 2014-09-15 Method
SG11201601939VA SG11201601939VA (en) 2013-09-16 2014-09-15 Method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG11201601939VA SG11201601939VA (en) 2013-09-16 2014-09-15 Method

Publications (1)

Publication Number Publication Date
SG11201601939VA true SG11201601939VA (en) 2016-04-28

Family

ID=52666048

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201601939VA SG11201601939VA (en) 2013-09-16 2014-09-15 Method

Country Status (4)

Country Link
US (2) US20160220613A1 (en)
JP (1) JP2017526723A (en)
SG (1) SG11201601939VA (en)
WO (1) WO2015038075A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019060719A1 (en) * 2017-09-22 2019-03-28 University Of Miami Methods and compositions for the treatment of epidermolysis bullosa
CN105324391A (en) 2013-04-16 2016-02-10 奥尔布森治疗学有限公司 Medical use of syndecan-2
CN107106614A (en) * 2014-09-15 2017-08-29 新加坡科技研究局 Graft versus host disease(GVH disease) is treated with excretion body(GVHD)Or epidermolysis bollosa(EB)Method
JP2017510542A (en) 2014-01-31 2017-04-13 ファクター バイオサイエンス インコーポレイテッド Methods and products for nucleic acid production and delivery
EP3271396A1 (en) 2015-03-20 2018-01-24 Orbsen Therapeutics Limited Modulators of syndecan-2 and uses thereof
CN108697740A (en) * 2015-11-18 2018-10-23 佐治亚大学研究基金会 The outer vesica of nerve cell
US20190015331A1 (en) * 2016-01-15 2019-01-17 Orbsen Therapeutics Limited Sdc-2 exosome compositions and methods of isolation and use
CN109803977A (en) 2016-08-17 2019-05-24 菲克特生物科学股份有限公司 Nucleic acid product and its method of administration
CN106913583A (en) * 2017-04-20 2017-07-04 深圳市赛欧细胞生物科技有限公司 The preparation method and application of human mesenchymal stem cell source excretion body biologically active agents
WO2019035880A1 (en) * 2017-08-15 2019-02-21 Children's Medical Center Corporation Purifield mesenchymal stem cell exosomes and uses thereof
WO2019217091A1 (en) * 2018-04-30 2019-11-14 Children's Medical Center Corporation Mesenchymal stromal cell exosomes and uses thereof
WO2019213501A1 (en) * 2018-05-04 2019-11-07 Spinalcyte, Llc De-differentiated fibroblast-conditioned media for stimulation of disc regeneration
US10501404B1 (en) 2019-07-30 2019-12-10 Factor Bioscience Inc. Cationic lipids and transfection methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2254586E (en) * 2008-02-22 2015-05-18 Agency Science Tech & Res Mesenchymal stem cell particles
SG2014010706A (en) * 2010-10-18 2014-05-29 Agency Science Tech & Res Method and composition
SG183579A1 (en) * 2011-02-11 2012-09-27 Agency Science Tech & Res Methods of detecting therapeutic exosomes
SG11201407626QA (en) * 2012-05-18 2014-12-30 Agency Science Tech & Res Umbilical cord mesenchymal stem cell exosomes
EP2687219A1 (en) * 2012-07-18 2014-01-22 Universität Duisburg-Essen Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
CN103767985A (en) * 2012-10-22 2014-05-07 吉林省霍普金斯药物研究院有限责任公司 Preparation and application of exosome secreted by human derived blood or mesenchymal stem cell

Also Published As

Publication number Publication date
US20160220613A1 (en) 2016-08-04
JP2017526723A (en) 2017-09-14
WO2015038075A1 (en) 2015-03-19
US20170258845A1 (en) 2017-09-14

Similar Documents

Publication Publication Date Title
GB201311001D0 (en) Lucabella
GB201413149D0 (en) No details
GB2520596B (en) Manufacturing method
GB201314695D0 (en) Method
HK1222846A1 (en) Substituted benzylpyrazoles
IL246002D0 (en) Novel methods
HK1221717A1 (en) Substituted benzylpyrazoles
PL2953956T3 (en) Heteropolyoxometalates
GB2510821B (en) Charging Method
SG11201601939VA (en) Method
GB201303430D0 (en) Communications method
GB201300957D0 (en) Sequencing method
EP2952098A4 (en) Pest-control method
GB201302789D0 (en) Apparatus
EP2946845A4 (en) Press-molding method
PL2994467T3 (en) Arylquinazolines
EP2957205A4 (en) Hand-dryer
GB2514689B (en) Quick-Coupler
GB201300376D0 (en) Method and compound
EP3000028A4 (en) Auto-calendaring
ZA201505682B (en) Microanchor
GB201318465D0 (en) Method
GB2515889B (en) Casting method
LT2961752T (en) Substituted imidazopyridazines
GB201300928D0 (en) Apparatus